FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Biotechnology Whitepapers

FierceBiotech’s selection of whitepapers contains case studies and research on business and technology issues affecting life sciences. If you would like to submit a whitepaper to the library, please contact our advertising team.



The 3W Gaurrantee: What you Really Saved when you invest in Outsourced Talent

Source: 
Internet
Author: 
Bruce Mills
This paper is written to help 3W partners learn the real value of Outsourcing. It will give executives a background of the global economy. At the same time, it gives a clear picture of how business Read more...

The FDA Review Process: a Technical Look

Source: 
GlobalSubmit
Navigating eCTD regulations is easier said than done. Same goes for assembling and reviewing applications. This white paper covers the full FDA review process to help you create an application that Read more...

Pharma is Moving to Digital & Social Media. Wake up!

Source: 
QuantumMethod
Author: 
George Tierney, Co-Founder, QuantumMethod
It's happening right now, all around us. Some of it is under the radar, some of it right out in the open. In spite of the cries for FDA guidance, which seems like it will never come, or fears of Read more...

The Cutting Edge of Chemistry

Source: 
The Cutting Edge of Chemistry
The Cutting Edge of Chemistry is a free report from Thomson Reuters, delivering an action-packed review of the latest synthesis schemes, scaffolds, mechanisms of action, and new structures shaping Read more...

Central Nervous System (CNS) Compound Library from OTAVA

Source: 
Ukraine
Author: 
Otavateam
There are many different drug targets expressed in brain tissue. The delivery of drugs to central nervous system (CNS) is complicated by blood brain barrier (BBB) which controls entry of drugs Read more...

Otava Lead-Like Library

Source: 
Otava Ltd
Author: 
Otava team
The preclinical drug-discovery process requires the screening of millions of small organic molecules to find a suitable lead compound for one ultimately successful outcome. A lead compound in Read more...

Tar Heel Biotech: The Policies, Trends, and Investments That Continue to Promote Growth in North Carolina's Biotechnology Sector

Source: 
Michael F. Easley, Jr.
Author: 
Michael F. Easley, Jr.
In the midst of a struggling national economy, North Carolina has emerged as biotechnology powerhouse, boasting over 500 biotech companies and nearly 57,000 biotech jobs. This paper analyzes the Read more...

Biologically Active Molecules: Chemical Research, Development and Scale-up

Source: 
http://www.otavachemicals.com/products/biochemicals
Author: 
Otava ltd
The increasing demand for different biologically active molecules has posed challenges to the scientists to get the desired substances in large amounts either from natural sources or to produce Read more...

Avoiding Post-Acquisition Product Sales Failures

Source: 
SalesForce4Hire
Author: 
Kevin Schimelfenig

When Post-Acquisition Product Sales Fail To Meet Expectations While mergers and acquisitions stalled in the wake of the global financial crisis and concerns over healthcare reform, activity has

Read more...

The National Provider Identifier (NPI) and its Impact on the Pharmaceutical and Medical Device Industries

Source: 
HCPlexus
Author: 
David Shrier, CEO, HCPlexus

As detailed in the Physician Payments Sunshine Provisions (PPSP), all vendors within the healthcare industry that interact with providers must disclose all transfers of monetary value annually to the

Read more...

Can a R&D Tax Credit Expand Investment in Product Development for Global Health?

Source: 
Center for Global Health R&D Policy Assessment
Author: 
Aarthi Rao

Tax credits are used throughout the world to encourage investment in R&D, but are tax credits a good tool to stimulate more R&D for diseases of the poor? The Center for Global Health R&D

Read more...

WHITE PAPER: Four Strategies for Cost-Effective Pharmacovigilance

Source: 
Drug Safety Alliance
Developing drug safety and pharmacovigilance programs has become increasingly complex amid challenging economic conditions. This paper presents four key areas in which pharmaceutical and biotech Read more...

Best Practices: ERP Vendor Reference-Checking

Source: 
Expandable Software
Author: 
Bob Swedroe, CEO, Expandable Software
Selecting an ERP solution can be a formidable challengeEspecially for a medtech manufacturing business.That's because you've got so much on the line: the wrong ERP selection can impact compliance, Read more...

Launching a Medical Device, Healthcare or Life Science Product: Fail Fast, Marginal or Worth Pursuing?

Source: 
SalesForce4Hire
Author: 
By Kevin Schimelfenig, Managing Partner of SalesForce4Hire®
The speed to market, accelerated sales growth and risk mitigation for a medical device, life science or healthcare product is critical to the success of a business. Whether you are planning to launch Read more...

The Adverse Impact of the US Reimbursement System on the Development and Adoption of Personalized Medicine Diagnostics

Source: 
Boston Healthcare Associates and the Personalized Medicine Coalition (PMC)
Author: 
David Parker, PhD, Vice President, Boston Healthcare
CONTACT Gwen Gordon Phone: (202) 589-1770 ggordon@PersonalizedMedicineCoalition.org Michal Taton Phone: (617) 912-5119 mtaton@bostonhealthcare.com Personalized Medicine Coalition Read more...